NO970308L - Heterosykliske forbindelser som er anvendbare som allosteriske effektorer ved muskarinske reseptorer - Google Patents

Heterosykliske forbindelser som er anvendbare som allosteriske effektorer ved muskarinske reseptorer

Info

Publication number
NO970308L
NO970308L NO970308A NO970308A NO970308L NO 970308 L NO970308 L NO 970308L NO 970308 A NO970308 A NO 970308A NO 970308 A NO970308 A NO 970308A NO 970308 L NO970308 L NO 970308L
Authority
NO
Norway
Prior art keywords
group
formula
sulfonamide
optionally substituted
muscarinic receptors
Prior art date
Application number
NO970308A
Other languages
English (en)
Other versions
NO970308D0 (no
Inventor
Nigel Birdsall
Sebastian Lazareno
Syunji Naruto
Sugimoto Masahiko
Kazuo Koyama
Shinji Marumoto
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415175A external-priority patent/GB9415175D0/en
Priority claimed from GB9423948A external-priority patent/GB9423948D0/en
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO970308D0 publication Critical patent/NO970308D0/no
Publication of NO970308L publication Critical patent/NO970308L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Forbindelser av formel (I) Y2, Yl (I) hvori Z betegner en metylengruppe, en metingruppe, en gruppe av formel >NH eller en gruppe av formel >N-, og W betegner en metylengruppe, en metin- gruppe, et svovelatom eller en gruppe av formel jiS-»(0),,, hvori v er 1 eller 2; _~_:__^ er en enkelt- eller dobbeltbinding; minst én av y\ Y^ Y^ og Y* betegner en karboksylgruppe, en sulfonamidgruppe eller en gruppe av formel -(A)p-B^-T*, hvori A er S eller 0, T^ er en karbok- sylgruppe, en tiokarboksygruppe, en ditiokarboksygruppe, en sulfonamid- gruppe eller en tetrazolylgruppe, B^ er en binding, en eventuelt substituert alkylengruppe og p er 0 eller 1; resten av Y^ Y^ Y' og Y^ er lik eller for- skjellig og er H, halogen, nitro, OH, SH, NHj, eventuelt substituert alkyl, alkoksy, alkyltio, alkylsulfinyl, alkylsulfonyl, aryl, aralkyloksy, aralkyltio, og Y^ + y^ kan sammen være et lakton eller keto; én av R^ og R^ er H, alkyl, alkanoyl, aryl, arylkarbonyl, aralkyl, karboksyl, sulfonamid eller en gruppe av formel -(0),-B'-T^ hvori T' er COOH, sulfonamid eller tetrazolyl, s^ er en eventuelt substituert alkylen, og q er 0 eller 1; den andre av R^ og r^ er H, alkyl, aryl eller aralkyl, eller R^ og R- betegner sammen en gruppe av for- mel (Ib') (Ib' ) hvori R'°, r" og R^^ er like eller for- skjellige, og hver er H, OH, halogen, haloalkyl, eventuelt substituert alkyl, alkoksy, alkyltio, alkylsulfinyl eller alkylsulfonyl; R' er H eller en amino- beskyttende gruppe; og farmasøytisk akseptable salter og estere derav er allosteriske effektorer ved muskarin- iske reseptorer og er anvendbare ved behandling og profylakse av sykdommer assosiert med muskariniske reseptorer.
NO970308A 1994-07-27 1997-01-24 Heterosykliske forbindelser som er anvendbare som allosteriske effektorer ved muskarinske reseptorer NO970308L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415175A GB9415175D0 (en) 1994-07-27 1994-07-27 Heterocyclic compounds, their preparation and their therapeutic use
GB9423948A GB9423948D0 (en) 1994-11-25 1994-11-25 Heterocyclic compounds, their preparation and their therapeutic use
PCT/JP1995/001494 WO1996003377A1 (en) 1994-07-27 1995-07-27 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors

Publications (2)

Publication Number Publication Date
NO970308D0 NO970308D0 (no) 1997-01-24
NO970308L true NO970308L (no) 1997-03-25

Family

ID=26305347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970308A NO970308L (no) 1994-07-27 1997-01-24 Heterosykliske forbindelser som er anvendbare som allosteriske effektorer ved muskarinske reseptorer

Country Status (14)

Country Link
US (1) US5877199A (no)
EP (1) EP0804416A1 (no)
KR (1) KR970704687A (no)
CN (1) CN1166169A (no)
AU (1) AU686426B2 (no)
CA (1) CA2196046A1 (no)
CZ (1) CZ24197A3 (no)
FI (1) FI970328A7 (no)
HU (1) HUT76923A (no)
MX (1) MX9700696A (no)
NO (1) NO970308L (no)
NZ (1) NZ290199A (no)
RU (1) RU2152385C1 (no)
WO (1) WO1996003377A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217707A1 (en) * 1995-04-10 1996-10-17 Fujisawa Pharmaceutial Co., Ltd. Indole derivatives as cgmp-pde inhibitors
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
US6548296B1 (en) 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
EP1056452B1 (en) * 1998-02-23 2006-07-19 South Alabama Medical Science Foundation Indole-3-propionic acids, salts and esters thereof used as medicaments
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9924962D0 (en) * 1999-10-21 1999-12-22 Mrc Collaborative Centre Allosteric sites on muscarinic receptors
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
AU7705601A (en) 2000-07-25 2002-02-05 Merck & Co Inc N-substituted indoles useful in the treatment of diabetes
EP1349858B1 (en) 2000-11-02 2008-08-27 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
CA2459546A1 (en) * 2001-09-20 2003-03-27 Biocon Limited Modified alumina catalyst
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
EA010408B1 (ru) 2002-10-23 2008-08-29 Гленмарк Фармасьютикалс Лтд. Трициклические соединения для лечения воспалительных и аллергических нарушений, способы их приготовления и содержащие их фармацевтические составы
OA13154A (en) 2003-04-11 2006-12-13 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them.
JP2007502251A (ja) * 2003-08-15 2007-02-08 ユニヴェルシテ・ラヴァル ２位官能化及び２，７位二官能化カルバゾール類のモノマー類、オリゴマー類、及びポリマー類
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
EP1677794B1 (en) * 2003-09-12 2014-12-03 Elixir Pharmaceuticals, Inc. Methods of treating disorder
ES2315877T3 (es) 2004-06-18 2009-04-01 Biolipox Ab Indoles utiles en el tratamiento de inflamaciones.
WO2006011024A2 (en) * 2004-07-19 2006-02-02 Glenmark Pharmaceuticals Ltd. New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
KR100875870B1 (ko) * 2004-10-14 2008-12-26 에프. 호프만-라 로슈 아게 항암제로서의 신규 아자인돌 티아졸리논
ES2349416T3 (es) * 2004-10-25 2011-01-03 Eli Lilly And Company Tienopiridinas como potenciadores alostéricos del receptor muscarínico m4.
JP3997491B2 (ja) 2004-10-29 2007-10-24 ゼリア新薬工業株式会社 カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩
BRPI0517211B8 (pt) 2004-12-17 2021-05-25 Glenmark Pharmaceuticals Sa composto, composição farmacêutica e seu uso.
US7943634B2 (en) 2004-12-17 2011-05-17 Glenmark Pharmaceuticals S.A. Substituted benzo[4,5]furo[3,2-c]pyridine derivatives as PDE 4 inhibitors
CN101142185A (zh) 2005-01-19 2008-03-12 比奥里波克斯公司 用于炎症治疗的吲哚
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
DK2669270T3 (en) 2011-01-28 2018-02-26 Sato Pharma Indole-related compounds such as URAT1 inhibitors
WO2013059245A1 (en) 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
CN103159934B (zh) * 2011-12-13 2016-01-13 海洋王照明科技股份有限公司 含并噻唑单元的聚合物及其制备方法和太阳能电池器件
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2970177A1 (en) 2013-03-15 2016-01-20 Pfizer Inc. Indole compounds that activate ampk
CN104530007A (zh) * 2014-12-08 2015-04-22 湖南大学 一种单取代咔唑硫醚化合物的制备方法
WO2020072580A1 (en) * 2018-10-02 2020-04-09 Disc Medicine, Inc. Matriptase 2 inhibitors and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1675478A (en) * 1924-01-24 1928-07-03 Grasselli Dyestuff Corp Dyestuff intermediates
US3687969A (en) * 1970-06-02 1972-08-29 Sterling Drug Inc 9-aroyl-1,2,3,4-tetrahydrocarbazole-3,3-dicarboxylic acids
DE2337154C2 (de) * 1973-07-18 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue Carbazolderivate
US4178289A (en) * 1978-06-26 1979-12-11 Hoffmann-La Roche Inc. Carbazole acetic acid derivatives
EP0234708B1 (en) * 1986-01-23 1991-02-27 Merck Frosst Canada Inc. Tetrahydrocarbazole 1-alkanoic acids
US4988820A (en) * 1986-02-21 1991-01-29 Bayer Aktiengesellschaft Cycloalkano(1,2-B) indole-sulponamides
US5200419A (en) * 1990-05-21 1993-04-06 Warner-Lambert Company Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
TW239127B (no) * 1991-12-20 1995-01-21 Hoffmann La Roche
JPH06298732A (ja) * 1993-02-16 1994-10-25 Taisho Pharmaceut Co Ltd インドール誘導体
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.

Also Published As

Publication number Publication date
MX9700696A (es) 1997-04-30
NZ290199A (en) 1999-06-29
NO970308D0 (no) 1997-01-24
CZ24197A3 (en) 1997-08-13
HUT76923A (hu) 1998-01-28
FI970328A7 (fi) 1997-03-27
KR970704687A (ko) 1997-09-06
EP0804416A1 (en) 1997-11-05
CA2196046A1 (en) 1996-02-08
RU2152385C1 (ru) 2000-07-10
FI970328A0 (fi) 1997-01-27
AU3086695A (en) 1996-02-22
AU686426B2 (en) 1998-02-05
WO1996003377A1 (en) 1996-02-08
CN1166169A (zh) 1997-11-26
US5877199A (en) 1999-03-02

Similar Documents

Publication Publication Date Title
NO970308L (no) Heterosykliske forbindelser som er anvendbare som allosteriske effektorer ved muskarinske reseptorer
WO2001087845A3 (en) N-containing heterocyclic compounds and their use as 5-ht antagonists
RU2000128033A (ru) Гетероциклические производные глицил-бета-аланина в качестве антагонистов витронектина
MXPA03011782A (es) Piridinas sustituidas herbicidas, su preparacion y su uso como herbicidas y reguladores del crecimiento de las plantas.
WO2000047580A3 (en) Phenyl urea and phenyl thiourea derivatives
ATE117295T1 (de) 4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung.
FI904602A0 (fi) Pyrazoloderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
ES8802220A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos.
RU2003127736A (ru) Ингибитора металлопротеиназ
DE69523574D1 (de) Carbapenem-derivate
EP0640080A1 (en) SUBSTITUTED INDOLE AND AZAINDOLE AS ANGIOTENSIN II ANTAGONISTS.
KR970703324A (ko) 신규한 피리미딘 유도체(novel pyrimidine derivative)
PT1021405E (pt) Derivados de azetidinona para o tratamento de infeccoes de hcmv
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
CA2285535A1 (en) Benzimidazole derivative for treating allergy-related disease
NZ504316A (en) Pyrimidine substituted carboxylic acid derivatives which have amido side-chains useful as endothelin receptor antagonists
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
ATE358128T1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
RU97103323A (ru) Производные пиразина с гербицидной активностью
DK1106614T3 (da) 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
HUP9900914A2 (hu) Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok
DE60027908D1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
EP0485219A3 (en) Medicaments for preventing and treating circulatory organ diseases containing spiro-3-heteroazolidine compounds
NO933115L (no) 3-oksadiazolyl-1,6-naftyridinderivater